BIOLOGICAL PROPERTIES AND BIOTECHNOLOGICAL ASPECTS OF PRODUCING A RECOMBINANT FORM OF LACTOFERRIN

Authors

  • Mikhail A. Khrustalev Ural Federal University named after the first President of the Russian Federation B.N. Yeltsin, Yekaterinburg
  • Kinan S. Darkazanli Institute of Chemical Technology, Ural Federal University named after the first President of the Russian Federation B.N. Yeltsin, Yekaterinburg
  • Aleksander V. Semenov Institute of Natural Sciences and Mathematics, Ural Federal University named after the first President of the Russian Federation B.N. Yeltsin, Yekaterinburg, Russia, Yekaterinburg
  • Elena G. Kovaleva Institute of Chemical Technology, Ural Federal University named after the first President of Russia B.N. Yeltsin, Yekaterinburg

Keywords:

lactoferrin, transferrins, recombinant protein, antipathogenic activity, iron-binding activity, immunomodulation, innate immunity, biosynthesis

Abstract

This scientific article is devoted to a comprehensive analysis of the biological and functional properties of lactoferrin, a multifunctional iron-binding glycoprotein from the transferrin family that plays a fundamental role in modulating human innate immunity. The paper examines in detail the molecular mechanisms of its specific activity: antibacterial, antiviral, and antifungal effects, as well as pronounced anti-inflammatory efficacy. These properties are successfully realized both through the direct release of Fe3+ iron ions, essential for pathogen metabolism and vital activity, and through direct interaction with host cell membranes and receptors, which facilitates effective regulation of the systemic immune response and cytokine profile. The relevance of the technological transition from the laborintensive process of extracting native protein from natural animal sources to modern, high-tech methods for the biosynthesis of its recombinant analogues is substantiated. Despite the naturally high concentration of lactoferrin in mammalian milk, traditional isolation methods carry risks of product contamination with hormones, allergens, and latent pathogens, and are characterized by prohibitively high costs due to multi-step purification procedures. This study proposes and describes in detail an optimized biotechnological model for producing a recombinant lactoferrin homologue. Based on a comparative analysis of various available expression systems, the author selected the most promising platforms and producer strains, ensuring not only a high yield of the target protein but also guaranteed preservation of its correct native conformation and full biological value. The obtained results are of high practical significance and can be directly applied in the development of scalable, cost-effective, and safe technologies for the industrial production of highly pure therapeutic biologics, which are in high demand in modern pharmacology, clinical nutrition, and the functional food industry

Author Biographies

Mikhail A. Khrustalev, Ural Federal University named after the first President of the Russian Federation B.N. Yeltsin, Yekaterinburg

PhD student (Biotechnology), Department of Organic Synthesis Technology, Institute of Chemical Technology, Research Engineer

Kinan S. Darkazanli, Institute of Chemical Technology, Ural Federal University named after the first President of the Russian Federation B.N. Yeltsin, Yekaterinburg

PhD (Biology), Junior Researcher, Laboratory of Biotransformation Technologies and Food Chemistry, Scientific, Educational and Innovative Center for Chemical-Pharmaceutical Technologies

Aleksander V. Semenov, Institute of Natural Sciences and Mathematics, Ural Federal University named after the first President of the Russian Federation B.N. Yeltsin, Yekaterinburg, Russia, Yekaterinburg

Doctor of Biological Sciences, Professor, Director, Federal Research Institute of Viral Infections “Virom” of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing; Professor, Department of Experimental Biology and Biotechnology

Elena G. Kovaleva, Institute of Chemical Technology, Ural Federal University named after the first President of Russia B.N. Yeltsin, Yekaterinburg

Doctor of Chemical Sciences, Professor of the Department of Organic Synthesis Technologies, Institute of Chemical Engineering

References

Sanchez L., Calvo M., Brock J.H. Biological role of lactoferrin. Archives of Disease in Child-hood, 1992, vol. 67, no. 5, pp. 657–661. 2. Sokolov A.V., Ivanov V.A., Kostevich V.A., Gorbunov N.P., Voynova I.V., Vasilyev V.B., Gusev S.A., Panasenko O.M. Ability of lactoferrin to inhibit oxidative/halogenative stress and improve wound healing in rats with experimental hyperglycemia. Medical academic journal, 2024, vol. 24, no. 4, pp. 74–83. DOI: 10.17816/MAJ636130

González-Chávez S.A., Arévalo-Gallegos S., Rascón-Cruz Q. Lactoferrin: structure, function and applications. International Journal of Antimicrobial Agents, 2009, vol. 33, iss. 4, pp. 301.e1–301.e8. DOI: 10.1016/j.ijantimicag.2008.07.020 4. Arzumanian V.G., Kolyganova T.I., Svitich O.A., Samoylikov P.V., Konanykhina S.Y., Zaytseva T.A., Zverev V.V. An impact of lactoferrin, serum albumin and secretory immunoglobulin A in actimicrobial activity of breast milk whey. Russian Journal of Infection and Immunity, 2022, vol. 12, no. 3, pp. 519–526. DOI: 10.15789/2220-7619-GPO-1759. 5. Crago S.S., Prince S.J., Pretlow T.G., McGhee J.R., & Mestecky J. Human colostral cells. I. Sepa-ration and characterization. Clinical and Experimental Immunology, 1979, vol. 38(3), pp. 585–592.

Anand N. (2024) Antiparasitic activity of the iron-containing milk protein lactoferrin and its potential derivatives against human intestinal and blood parasites. Front. Parasitol. 2024, vol. 2, art. no. 1330398. DOI: 10.3389/fpara.2023.1330398

Baker E.N., Baker H.M. Molecular structure, binding properties and dynamics of lactoferrin. Cellular and Molecular Life Sciences, 2005, vol. 62, no. 22, pp. 2531–2539. DOI: 10.1007/s00018-005-5368-9

Gruden Š., Poklar Ulrih N. Diverse Mechanisms of Antimicrobial Activities of Lactoferrins, Lactoferricins, andOther Lactoferrin-Derived Peptides. Int. J. Mol. Sci., 2021, vol. 22, art. no. 11264. DOI: 10.3390/ ijms222011264 9. Tanaka T., Omata Y., Saito A., Shimazaki K., Igarashi I., Suzuki N. Growth inhibitory effects of bovine lactoferrin to Toxoplasma gondii parasites in murine somatic cells. J Vet Med Sci., 1996, vol. 58(1), pp. 61–65. DOI: 10.1292/jvms.58.61. 10. Wakabayashi H., Uchida K., Yamauchi K., Teraguchi S., Hayasawa H., Yamaguchi H. Lactoferrin given in food facilitates dermatophytosis cure in guinea pig models. J Antimicrob Chemother, 2000, vol. 46(4), pp. 595–602. DOI: 10.1093/jac/46.4.595. 11. Cutone A., Rosa L., Ianiro G., Lepanto M.S., Bonaccorsi di Patti M.C., Valenti P., Musci G. Lactoferrin's Anti-Cancer Properties: Safety, Selectivity, and Wide Range of Action. Biomolecules, 2020, vol. 10(3), art. no. 456. DOI: 10.3390/biom10030456. 12. Legrand D., Elass E., Carpentier M., Mazurier J. Lactoferrin: a modulator of immune and in-flammatory responses. Cell Mol Life Sci., 2005, vol. 62(22), pp. 2549–2559. DOI: 10.1007/s00018-005-5370-2. 13. Paesano R., Berlutti F., Pietropaoli M., Goolsbee W., Pacifici E., Valenti P. Lactoferrin effica-cy versus ferrous sulfate in curing iron disorders in pregnant and non-pregnant women. Int J Immunopathol Pharmacol., 2010, vol. 23(2), pp. 577–587. DOI: 10.1177/039463201002300220. 14. Cheng Y., Zak O., Aisen P., Harrison S.C., Walz T. Structure of the human transferrin recep-tor-transferrin complex. Cell, 2004, vol. 116(4), pp. 565–576. DOI: 10.1016/s0092-8674(04)00130-8.

Steere A.N., et al. The transferrin cycle: molecular mechanisms of iron uptake and release. Progress in Molecular Biology and Translational Science, 2012, vol. 110, pp. 103–157.

Baker E. N. New perspectives on the structure and function of transferrins / E.N. Baker, P.F. Lindley // Journal of Inorganic Biochemistry. 1992. Vol. 47, № 3-4. P. 147–160. DOI: 10.1016/0162-0134(92)84061-Q 17. Bobreneva I.V., Rokhlova M.V. Lactoferrin: properties and application. A review. Theory and practice of meat processing, 2021, vol. 6(2), pp. 128–134. DOI: 10.21323/2414-438X-2021-6-2-128-134 18. Jańczuk A., Brodziak A., Czernecki T., Król J. Lactoferrin-The Health-Promoting Properties and Contemporary Application with Genetic Aspects. Foods, 2022, vol. 12(1), art. no. 70. DOI: 10.3390/foods12010070.

Published

2026-06-28

Issue

Section

Applied Biochemistry and Biotechnology